TSC2 and neoplasm: Mutations in TSC1 and/or TSC2 genes, encoding for hamartin and tuberin respectively, have been implicated in this disease, disrupting the mechanistic target of the rapamycin pathway, and consequently promoting tumour formation across organs [1, 2].